SHMT2 expression can also be upregulated through the IL-6/JAK2/STAT3 regulatory pathway in human prostate carcinoma LNCaP cells, speeding up the cell transition towards more advanced stages 45. The gene discussed is SHMT2; the disease is prostate carcinoma.